Literature DB >> 16941474

Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies.

Raül Santamaria1, Amparo Chabás, Maria Josep Coll, Clara Sa Miranda, Lluïsa Vilageliu, Daniel Grinberg.   

Abstract

GM1-gangliosidosis and Morquio B disease are rare lysosomal storage disorders caused by beta-galactosidase deficiency due to mutations in the GLB1 gene. Three major clinical forms of GM1-gangliosidosis have been established on the basis of age of onset and severity of symptoms: infantile, late infantile/juvenile, and adult. We performed mutation analysis on 30 GM1-gangliosidosis and five Morquio B patients, mainly of Spanish origin, and all the causative mutations were identified. Thirty different mutations were found, 21 of which were novel. With the exception of two adults and one juvenile patient, all the GM1-gangliosidosis patients were affected by the infantile form. Clinical findings are presented for all patients. We report the association of the novel mutations p.T420K and p.L264S with the adult form and the juvenile form, respectively. In addition, the novel mutation p.Y83C was associated with Morquio B disease. Among the 30 GM1-gangliosidosis patients, 6 were of Gypsy origin (Roma). Moreover, those six Gypsy patients shared not only the same mutation (p.R59H) but also a common haplotype. This observation indicates a possible founder effect in this group and suggests that screening of the p.R59H mutation may be appropriate in GM1-gangliosidosis patients of Gypsy origin. This is the first exhaustive mutational analysis performed in a large group of Iberian GM1-gangliosidosis and Morquio B patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941474     DOI: 10.1002/humu.9451

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  22 in total

1.  β-Galactosidosis in Patient with Intermediate GM1 and MBD Phenotype.

Authors:  Tereza Moore; Jonathan A Bernstein; Sylvie Casson-Parkin; Tina M Cowan
Journal:  JIMD Rep       Date:  2012-04-22

2.  Newborn screening for lysosomal storage disorders in hungary.

Authors:  Judit Wittmann; Eszter Karg; Sàndor Turi; Elisa Legnini; Gyula Wittmann; Anne-Katrin Giese; Jan Lukas; Uta Gölnitz; Michael Klingenhäger; Olaf Bodamer; Adolf Mühl; Arndt Rolfs
Journal:  JIMD Rep       Date:  2012-03-21

3.  Clinical Findings and Natural History in Ten Unrelated Families with Juvenile and Adult GM1 Gangliosidosis.

Authors:  João Stein Kannebley; Laura Silveira-Moriyama; Laís Orrico Donnabella Bastos; Carlos Eduardo Steiner
Journal:  JIMD Rep       Date:  2015-06-25

4.  Clinical and molecular characteristics of 11 Chinese probands with GM1 gangliosidosis.

Authors:  Yuyu Feng; Yonglan Huang; Xiaoyuan Zhao; Huiying Sheng; Yi Feng; Wen Zhang; Li Liu
Journal:  Metab Brain Dis       Date:  2018-09-28       Impact factor: 3.584

Review 5.  The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis.

Authors:  Frederick M Lang; Paul Korner; Mark Harnett; Ajith Karunakara; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2019-12-30       Impact factor: 4.797

6.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

Review 7.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

8.  The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis.

Authors:  Fedah E Mohamed; Mohammad Al Sorkhy; Mohammad A Ghattas; Lihadh Al-Gazali; Osama Al-Dirbashi; Fatma Al-Jasmi; Bassam R Ali
Journal:  Hum Genet       Date:  2020-03-26       Impact factor: 4.132

9.  GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings.

Authors:  Anna Caciotti; Scott C Garman; Yadilette Rivera-Colón; Elena Procopio; Serena Catarzi; Lorenzo Ferri; Carmen Guido; Paola Martelli; Rossella Parini; Daniela Antuzzi; Roberta Battini; Michela Sibilio; Alessandro Simonati; Elena Fontana; Alessandro Salviati; Gulcin Akinci; Cristina Cereda; Carlo Dionisi-Vici; Francesca Deodato; Adele d'Amico; Alessandra d'Azzo; Enrico Bertini; Mirella Filocamo; Maurizio Scarpa; Maja di Rocco; Cynthia J Tifft; Federica Ciani; Serena Gasperini; Elisabetta Pasquini; Renzo Guerrini; Maria Alice Donati; Amelia Morrone
Journal:  Biochim Biophys Acta       Date:  2011-04-07

10.  Morquio-like dysostosis multiplex presenting with neuronopathic features is a distinct GLB1-related phenotype.

Authors:  Sylvia Stockler-Ipsiroglu; Nahid Yazdanpanah; Mojgan Yazdanpanah; Marioara Moisa Popurs; Nataliya Yuskiv; Mara Lúcia Schmitz Ferreira Santos; Chong Ae Kim; Carolina Fischinger Moura de Souza; Charles Marques Lourenço; Carlos Eduardo Steiner; Andressa Federhen; Luciana Giugliani; Débora Maria Bastos Pereira; Luz Elena Durán-Carabali; Roberto Giugliani
Journal:  JIMD Rep       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.